Back to Top Skip to main content Skip to sub-navigation

Early Identification of SARS-CoV-2 Emergence in the Department of Defense via Retrospective Analysis of 2019–2020 Upper Respiratory Illness Samples

Image of Army Maj. Raymond Nagley, S-3 officer assigned to the 50th Regional Support Group (RSG), receives a nasal swab to screen for COVID-19 at Fort Hood, Texas, on Feb. 5, 2021, from Spc. Yoali Muniz, a lab tech assigned to the 7406th Troop Medical Clinic, based in Columbia, Missouri. The 50th RSG, a Florida Guard unit based in Homestead, Florida, is preparing for deployment to Poland. (U.S. Army Guard photo by Sgt. 1st Class Shane Klestinski). Army Maj. Raymond Nagley, S-3 officer assigned to the 50th Regional Support Group (RSG), receives a nasal swab to screen for COVID-19 at Fort Hood, Texas, on Feb. 5, 2021, from Spc. Yoali Muniz, a lab tech assigned to the 7406th Troop Medical Clinic, based in Columbia, Missouri. The 50th RSG, a Florida Guard unit based in Homestead, Florida, is preparing for deployment to Poland. (U.S. Army Guard photo by Sgt. 1st Class Shane Klestinski)

Recommended Content:

Medical Surveillance Monthly Report

What are the New Findings?

The first reported confirmed SARS-CoV-2 infection in the U.S. was in Washington state on 21 January 2020 in an individual who had traveled to Wuhan, China. To determine if SARS-CoV-2 infections were present in the U.S. prior to that date, samples from a DOD respiratory surveillance program dating back to 1 December 2019, were evaluated for the presence of SARS-CoV-2 RNA. Viral RNA was not detected in any sample collected before 21 January 2020; however, positive samples were identified for several U.S. regions where the date of collection preceded the first reported infection for that region.

What is the Impact on Readiness and Force Health Protection?

The implementation of new and emerging pathogen detection assays into already established surveillance programs could detect community spread earlier, thereby reducing the spread of pathogen among vulnerable populations more effectively.

Abstract

The first U.S. case of non-travel-related severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was detected in late February 2020 in California, but the prevailing delay in diagnostic testing and initial stringent testing criteria made it difficult to identify those who could have acquired the virus through community spread. The emergence of the virus in the western Pacific region in late 2019 and the global distribution of Department of Defense (DOD) personnel present the risk that DOD members may have been exposed and contracted the virus earlier then U.S. detections. Here, a retrospective study from residual samples collected from a global DOD Respiratory Surveillance Program was conducted to establish a tentative timeline of when this virus began circulating in the DOD population. Quantitative real-time reverse-transcription polymerase chain reaction testing for SARS-CoV-2 was performed and the specimen collection dates of positive results were compared to the dates of the first infections previously identified in respective states and counties. Twenty-four positive samples were identified out of approximately 7,000 tested. Although this retrospective testing found early cases in 8 locations, there were no results indicative of circulation before late February.

Background

Although the first 2 decades of the 21st century were marked by the emergence of novel respiratory pathogens with pandemic potential (2003 SARS-CoV, 2009 Influenza A H1N1, and 2012 MERS-CoV), the recognition and spread of a highly infectious and unusually lethal strain of the human beta coronaviruses, i.e., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in late 2019 caught the world's health systems by surprise. The emergent nature of the coronavirus disease 2019 (COVID-19) pandemic resulted in most of the scientific literature being released through the medRxiv preprint server prior to peer-review. As such, the authors recommend critical consideration of the referenced literature. Even the most technologically advanced countries with the greatest wealth, such as the U.S., did not have sufficient pandemic preparedness plans in place to adapt to this outbreak.1 In fact, the lack of centralized planning was evident in the wide variation between states on recommendations for testing in the early outbreak period between March (when the virus first arrived in most states) and July 2020.2 Even the Department of Defense (DOD), with its numerous world-class infectious disease research institutes and clinical surveillance programs, was caught off-guard. However, the DOD quickly adapted and put into place a surveillance approach leveraging its established Upper Respiratory Surveillance program housed at the U.S. Air Force School of Aerospace Medicine (USAFSAM). This response resulted in a massive capability increase and the DOD has remained ready to execute its global mission.

The gaps in early testing led to widespread underestimation of infected individuals, with some early sampling results suggesting nearly 5% of undiagnosed people in the U.S. were seropositive for prior exposure to the virus.3 According to Kalish et al., this seropositivity rate translates to 5 undiagnosed infections per diagnosis between May and July 2020. An additional impact of the variable testing recommendations and the high infectivity of the virus was the emergence of local hotspots such as New Orleans during Mardi Gras,4 where only a few individuals imported the virus but many exported it elsewhere.

In order to better prepare for the next major outbreak, a more detailed and thorough understanding of the early emergence of this pandemic in the U.S. and DOD-associated populations is required. To that end, a retrospective analysis was performed of clinical remnants from patients who reported to military medical treatment facilities during the winter of 2019–2020 complaining of upper respiratory infections. This paper reports the findings from that study and implications for increasing the DOD's readiness for the next pandemic.

Methods

The Air Force Research Laboratory Institutional Review Board (Study number FWR20190037N) determined this study to be non-human subject research as part of a public health response activity and the study was conducted between March and June 2020.

Sample selection and testing

De-identified nasopharyngeal swab (NPS) samples were collected from a respiratory surveillance program that tracks influenza globally to aid in the yearly influenza vaccine development. Samples were stabilized in viral transport media prior to testing, covered the date range from 1 December 2019 to 3 June 2020, and originated from 86 military medical treatment facilities (MTFs) around the globe. USAFSAM (a DOD Reference Laboratory) previously tested these samples for upper respiratory infections using the Luminex Respiratory panel (Austin, TX) before being stored at -80º C. The Reference Laboratory provided the following metadata: date of collection, MTF, and co-infections.

Ribonucleic acid (RNA) was extracted from the NPS samples with Promega Maxwell 16 instruments using the Maxwell Total Viral RNA kit according to the manufacturer's instructions. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) testing was performed using the SuperScript III RT-PCR master mix (ThermoFisher, cat. #204454) with the research use only 2019-nCoV primer-probe kit (IDT DNA, cat. #10006605). Thermocycling conditions on the ABI 7500 FAST analyzer consisted of a 20-minute reverse transcription step at 50° C, a 10-minute hot-start activation step at 95° C, and 45 cycles of 95° C for 3 seconds followed by 55° C for 30 seconds.

Data analysis and statistics

In accordance with the approved Centers for Disease Control and Prevention (CDC) assay methodology, samples were positive for SARS-CoV-2 if the RNase P control passed (cycle threshold [Ct] < 40) and both primer sets N1 and N2 produced Ct values below 40. In the cases where RNase P did not amplify but both N1 and N2 were positive, those samples were called positive in accordance with the Food and Drug Administration-authorized instructions for use of the CDC 2019-nCoV RT-PCR Diagnostic Panel. Samples where only 1 of the 2 markers were detected were "inconclusive" and the test was repeated using the previously extracted RNA. Sample metadata and amplicon data, which had been stored separately, were combined by the Laboratory Director prior to analysis. MS Access 2013 (Microsoft Corporation, Redmond, WA) was used for data management and descriptive statistics such as number of positives, daily positive hit rate, and earliest detection.

Results

The observed positivity rate was 0.3% (24 positive samples from 7,021 total samples). Of these samples, 14 were collected from patients prior to the first COVID-19 case clinically reported at 8 different installations (Table 1). The first positive RT-PCR sample from Wright Patterson Air Force Base (AFB) in Ohio was collected a full month before the first laboratory-confirmed case at that installation (22 March 2020), and 2 days before the first laboratory-confirmed case in the DOD (26 February 2020 by U.S. Forces Korea).6 A second PCR-positive specimen of significant interest was collected at Ellsworth AFB 46 days before the first case of COVID-19 reported from the installation in South Dakota.

Samples were received from installations in 3 geographic combatant commands (Table 2): European Command (EUCOM), Pacific Command (PACOM), and Northern Command (NORTHCOM). The majority of test samples (89.3%) originated in NORTHCOM followed by PACOM (6.6%), and EUCOM (3.4%). An additional 47 samples originated in U.S. Coast Guard clinics (0.7%). Positive sample distribution included 20 from NORTHCOM (0.3% positive rate), 0 from PACOM, 4 from EUCOM (1.7% positive rate), and 0 from the Coast Guard.

The number of SARS-CoV-2 positives in this respiratory surveillance sample set increased logarithmically with time, mirroring the positivity rate observed in the larger pandemic (Figure). Beginning in the week ending 29 February, an increasing number of positive tests was observed until the week ending 28 March. The decline at the end of March was due to the addition of SARSCoV-2 clinical testing in the Air Force clinical test menu in early March. Therefore, most of the SARS-CoV-2 positive samples in March and beyond were evaluated directly by the clinical lab and not by the surveillance lab. The effect of clinical testing was also seen in that the peak sampling period was from mid-February to early March, when nearly one-third of all samples were collected. Notably, the effect was most dramatically seen in testing numbers between the weeks ending 21 March and 28 March, when 691 samples were tested compared with 90, respectively.

In addition to observing an increase in testing, two peaks were detected in the positivity rates. For the week ending 29 February, one sample was positive out of 333 tests, a rate of 0.30%. The following two weeks remained below 1% positive rate (0.17% and 0.37%, respectively) before increasing to 1.45% with 10 detections out of 688 tests for the week ending 21 March, and peaking at 3.33% with three positive tests out of 90 samples during the final week of the study. The week ending 4 April had no positive tests, but then the next three weeks had positivity rates of 1.4%, 3.1%, and 3.8% before another week of no positive tests and finally a week with 2.0% positivity (1/49 tests). These observations are consistent with the observed increase in nationwide infection growth beginning during the week ending 14 March.7

Editorial Comment

These results suggest that while the COVID-19 virus was present in the U.S. military population earlier than previously reported, the change in observed infection timing was minimal. Excluding the outlier from Ellsworth AFB, the initial positive specimens were collected approximately 2 weeks before the first cases were reported (average=11.6 days, range 2–27 days). These results are similar to the results of other retrospective testing studies that focused on PCR-based detection of residual samples.8-10 Evaluation of residual specimens using antibody tests is still an on-going effort and may lead to different data as better assays become available.11

Collectively, the retrospective testing results worldwide demonstrate that the early testing response was inadequate. In the U.S., the lead for testing is the Centers for Disease Control and Prevention, guiding the development and deployment of diagnostic assays. In steady-state operations this is a fully acceptable arrangement; however, as has been seen during this outbreak, relying solely upon a single organization for direction has shortcomings. In contrast, the DOD's use of centralized control coupled with broad, decentralized execution provides the flexibility and adaptability that are necessary for early investigation of disease outbreaks.

When military planners return to the table to develop the next public health emergency preparedness plan, they should consider Joint doctrine and the wealth of expertise that the DOD has spread across its agency. The biological defense and public health enterprises centered around the Defense Threat Reduction Agency, the Defense Advanced Research Projects Agency, and the Armed Forces Health Surveillance Division utilize advanced molecular technology and deploy those capabilities across the services. Data from technologies such as next generation sequencing for detection could feed directly into the research labs so that diagnostics, vaccines, and therapeutics could be continually generated and transitioned to the industrial infrastructure at the first sign of outbreak. Technology is available and in wide use today that was not available in December 2019 for detecting the earliest positives, but even with these advances in technology, as the results reported here demonstrate, outbreaks could be identified a matter of a few weeks earlier. For the next pandemic, the challenge is to have technology innovators engaged globally, and to adequately resource government, academic, and industry research labs to make a one month sequence-to-diagnostics turn-around a reality.

While more than 7,000 samples were tested in this study, the number of independent test sites is small and heavily favored by one Service. As expected a high proportion of samples originated from NORTHCOM facilities, where most of the DOD MTFs are located, while the overseas samples originated from 10 Air Force installations and 1 Army installation. In a demonstration of multi-agency collaboration, samples were received from 6 Coast Guard clinics, too. No samples were received from Southern Command and less than 10 samples from Central Command, so the impact of the epidemic in military members stationed in those regions is unknown. In order to provide adequate surveillance during normal operations and epidemics, the Military Health System, and the Defense Health Agency by extension, must increase the participation of sentinel sites in the Respiratory Surveillance Program. With 475 military hospitals and medical clinics across the globe, the DOD is the only health care system that is equipped to monitor worldwide infectious diseases before they enter the homeland. The surveillance network for the DOD is primed to immediately add validated assays for new and emerging infections in parallel with the clinical assays that are deployed, to actively track community spread once a virus has been detected by the CDC early in a pandemic.

Author affiliations: Department of Public Health and Preventive Medicine, U.S. Air Force School of Aerospace Medicine, Wright Patterson AFB, OH (all authors).

References

1. Cirilo ER, Natti PL, Romeiro NML, et al. One study of COVID-19 spreading at the United States – Brazil – Columbia. medRxiv preprint, 29 August 2020, https://doi.org/10.1101/2020.08.29.20184465 

2. Perniciaro SR and Weinberger DM. Variations in state-level SARS-CoV-2 testing recommendations in the United States, MarchJuly 2020. medRxiv preprint 24 September 2020, https://doi.org/10.1101/2021.01.27.21250570 

3. Kalish H, Klumpp-Thomas C, Hunsberger S, et al. Mapping a pandemic: SARS-CoV-2 seropositivity in the United States. medRxiv preprint, 27 January 2021, https://doi.org/10.1101/2021.01.27.21250570

4. Zeller M, Gangavarapu K, Anderson C, et al. Emergence of an early SARS-CoV-2 epidemic in the United States. medRxiv preprint, 05 February 2021, https://doi.org/10.1101/2021.02.05.21251235

5. Centers for Disease Control and Prevention. Division of Viral Diseases. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel Instructions for Use. Revision 03. Catalog # 2019-nCoVEUA-01. 

6. U.S. Department of Defense. Coronavirus: DOD Response Timeline. Accessed 15 June 2020. https://www.defense.gov/Explore/Spotlight/Coronavirus/DOD-Response-Timeline/ 

7. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). COVID-19 Dashboard. Accessed 15 June 2020. https://coronavirus.jhu.edu/map.html

8. Capalbo C, Bertamino E, Zerbetto A, et al. No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance. Int J Environ Res Public Health. 2020;17(22):8461. 

9. Yu X, Wei D, Chen Y, et al. Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness. Emerg Microbes Infect. 2020;9(1):1470. 

10. Hogan CA, Garamani N, Sahoo MK, et al. Retrospective Screening for SARS-CoV-2 RNA in California, USA, Late 2019. Emerg Infect Dis. 2020;26(10):2487. 

11. Basavaraju SV, Patton ME, Grimm K, et al. Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020. Clinl Infect Dis. 2020;ciaa1785.

FIGURE. Weekly and cumulative counts of SARS-CoV-2 tests and detections, 1 December 2019–3 June 2020

TABLE 1. Summary of SARS-CoV-2 positive samples

TABLE 2. Numbers of samples tested for SARS-CoV-2 and percentages positive, by month and region

You also may be interested in...

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Non-service Member Beneficiaries of the Military Health System, 2021

Article
6/1/2022

In 2021, mental health disorders accounted for the largest proportions of the morbidity and health care burdens that affected the pediatric and younger adult beneficiary age groups. Among adults aged 45–64 and those aged 65 or older, musculoskeletal diseases accounted for the most morbidity and health care burdens. As in previous years, this report documents a substantial majority of non-service member beneficiaries received care for current illness and injury from the Military Health System as outsourced services at non-military medical facilities.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance snapshot: Illness and injury burdens, reserve component, U.S. Armed Forces, 2021

Article
6/1/2022
Surveillance snapshot: Illness and injury burdens, reserve component, U.S. Armed Forces, 2021

Recommended Content:

Medical Surveillance Monthly Report

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Members, U.S. Armed Forces, 2021

Article
6/1/2022

As in previous years, among service members deployed during 2021, injury/poisoning, musculoskeletal diseases and signs/symptoms accounted for more than half of the total health care burden during deployment. Compared to garrison disease burden, deployed service members had relatively higher proportions of encounters for respiratory infections, skin diseases, and infectious and parasitic diseases. The recent marked increase in the percentage of total medical encounters attributable to the ICD diagnostic category "other" (23.0% in 2017 to 44.4% in 2021) is likely due to increases in diagnostic testing and immunization associated with the response to the COVID-19 pandemic.

Recommended Content:

Medical Surveillance Monthly Report

Medical Evacuations out of the U.S. Central and U.S. Africa Commands, Active and Reserve Components, U.S. Armed Forces, 2021

Article
6/1/2022
Medical Evacuations out of the U.S. Central and U.S. Africa Commands, Active and Reserve Components, U.S. Armed Forces, 2021

The proportions of evacuations out of USCENTCOM that were due to battle injuries declined substantially in 2021. For USCENTCOM, evacuations for mental health disorders were the most common, followed by non-battle injury and poisoning, and signs, symptoms, and ill-defined conditions. For USAFRICOM, evacuations for non-battle injury and poisoning were most common, followed by disorders of the digestive system and mental health disorders.

Recommended Content:

Medical Surveillance Monthly Report

Ambulatory Visits, Active Component, U.S. Armed Forces, 2021

Article
6/1/2022

In 2021, the overall numbers and rates of active component service member ambulatory care visits were the highest of any of the last 10 years. Most categories of illness and injury showed modest increases in numbers and rates. The proportions of ambulatory care visits that were accomplished via telehealth encounters fell to under 15% in 2021, compared to 19% in 2020.

Recommended Content:

Medical Surveillance Monthly Report

Hospitalizations, Active Component, U.S. Armed Forces, 2021

Article
6/1/2022

The hospitalization rate in 2021 was 48.0 per 1,000 person-years (p-yrs), the second lowest rate of the most recent 10 years. For hospitalizations limited to military facilities, the rate in 2021 was the lowest for the entire period. As in prior years, the majority (71.2%) of hospitalizations were associated with diagnoses in the categories of mental health disorders, pregnancy-related conditions, injury/poisoning, and digestive system disorders.

Recommended Content:

Medical Surveillance Monthly Report

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Active Component, U.S. Armed Forces, 2021

Article
6/1/2022

In 2021, as in prior years, the medical conditions associated with the most medical encounters, the largest number of affected service members, and the greatest number of hospital days were in the major categories of injuries, musculoskeletal disorders, and mental health disorders. Despite the pandemic, COVID-19 accounted for less than 2% of total medical encounters and bed days in active component service members.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Tick-borne Encephalitis in Military Health System Beneficiaries, 2012–2021

Article
5/1/2022
iStock—The castor bean tick (Ixoedes ricinus). Credit: Erik Karits

Tick-borne Encephalitis in Military Health System Beneficiaries, 2012–2021. Tick-borne encephalitis (TBE) is a viral infection of the central nervous system that is transmitted by the bite of infected ticks, mostly found in wooded habitats in parts of Europe and Asia

Recommended Content:

Medical Surveillance Monthly Report

Evaluation of ICD-10-CM-based Case Definitions of Ambulatory Encounters for COVID-19 Among Department of Defense Health Care Beneficiaries

Article
5/1/2022
SEATTLE, WA, UNITED STATES 04.05.2020 U.S. Army Maj. Neil Alcaria is screened at the Seattle Event Center in Wash., April 5. Soldiers from Fort Carson, Colo., and Joint Base Lewis-McChord, Wash. have established an Army field hospital center at the center in support of the Department of Defense COVID-19 response. U.S. Northern Command, through U.S. Army North, is providing military support to the Federal Emergency Management Agency to help communities in need. (U.S. Army photo by Cpl. Rachel Thicklin)

This is the first evaluation of ICD-10-CM-based cased definitions for COVID-19 surveillance among DOD health care beneficiaries. The 3 case definitions ranged from highly specific to a lower specificity, but improved balance between sensitivity and specificity.

Recommended Content:

Medical Surveillance Monthly Report

Update: Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2013–2021

Article
5/1/2022
This illustration depicts a 3D computer-generated image of a number of drug-resistant Neisseria gonorrhoeae bacteria. CDC/James Archer

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2013–2021. In general, compared to their respective counterparts, younger service members, non-Hispanic Black service members, those who were single and other/unknown marital status, and enlisted service members had higher incidence rates of STIs.

Recommended Content:

Medical Surveillance Monthly Report

The Association Between Two Bogus Items, Demographics, and Military Characteristics in a 2019 Cross-sectional Survey of U.S. Army Soldiers

Article
5/1/2022
NIANTIC, CT, UNITED STATES 06.16.2022 U.S. Army Staff Sgt. John Young, an information technology specialist assigned to Joint Forces Headquarters, Connecticut Army National Guard, works on a computer at Camp Nett, Niantic, Connecticut, June 16, 2022. Young provided threat intelligence to cyber analysts that were part of his "Blue Team" during Cyber Yankee, a cyber training exercise meant to simulate a real world environment to train mission essential tasks for cyber professionals. (U.S. Army photo by Sgt. Matthew Lucibello)

Data from surveys may be used to make public health decisions at both the installation and the Department of the Army level. This study demonstrates that a vast majority of soldiers were likely sufficiently engaged and answered both bogus items correctly. Future surveys should continue to investigate careless responding to ensure data quality in military populations.

Recommended Content:

Medical Surveillance Monthly Report

Exertional Heat Illness at Fort Benning, GA: Unique Insights from the Army Heat Center

Article
4/1/2022
Navy Petty Officer 3rd Class Ryan Adams is being used as an example victim for cooling a heat casualty at the bi-annual hot weather standard operating procedure training aboard Marine Corps Base Camp Lejeune, N.C., Aug. 24. Adams is demonstrating the "burrito" method used to cool a heat related injury victim. Photo by Pfc. Joshua Grant.

Exertional heat illness (hereafter referred to as heat illness) spans a spectrum from relatively mild conditions such as heat cramps and heat exhaustion, to more serious and potentially life-threatening conditions such as heat injury and exertional heat stroke (hereafter heat stroke).

Recommended Content:

Medical Surveillance Monthly Report

Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2017–2021

Article
4/1/2022
The Embry-Riddle Army ROTC Ranger Challenge team heads out on the 12-mile road march after completing the timed obstacle course event of the 6th Brigade Army ROTC Ranger Challenge January 14, 2022 at Fort Benning, Ga. The Titan Brigade’s Ranger Challenge took place at Fort Benning, Ga. January 13-15, 2022. Photo by Capt. Stephanie Snyder

Exertional rhabdomyolysis is a potentially serious condition that requires a vigilant and aggressive approach. Some service members who experience exertional rhabdomyolysis may be at risk for recurrences, which may limit their military effectiveness and potentially predispose them to serious injury.

Recommended Content:

Medical Surveillance Monthly Report

Heat Illness, Active Component, U.S. Armed Forces, 2021

Article
4/1/2022
Airmen participate in the 13th Annual Fallen Defender Ruck March at Joint Base San Antonio, Nov. 6, 2020. The event honors 186 fallen security forces, security police and air police members who have made the ultimate sacrifice. Photo By: Sarayuth Pinthong, Air Force.

From 2020 to 2021, the rate of incident heat stroke was relatively stable while the rate of heat exhaustion increased slightly

Recommended Content:

Medical Surveillance Monthly Report

Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2006–2021

Article
4/1/2022
Marine Corps Cpl. Luis Alicea drinks water after a combat conditioning exercise at Naval Air Station Joint Reserve Base New Orleans, May 20, 2019. Photo By: Marine Corps Lance Cpl. Jose Gonzalez.

Exertional (or exercise-associated) hyponatremia refers to a low serum, plasma, or blood sodium concentration (below 135 mEq/L) that develops during or up to 24 hours following prolonged physical activity. Acute hyponatremia creates an osmotic imbalance between fluids outside and inside of cells.

Recommended Content:

Medical Surveillance Monthly Report
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 12
Refine your search
Last Updated: August 23, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.